Balram Bhargava

COVID-19 vaccine booster shots in Bikaner

Exclusive: Nobody Approved India’s COVID-19 ‘Precautionary’ Doses

Banjot Kaur 22/07/2022

Neither the CDSCO nor the national advisory group on...

annie-spratt-5cFwQ-WMcJU-unsplash

One Paper Retracted After Plagiarism, Other Complaints Against ICMR Virology Chief

Sayantan Datta 29/05/2022

One of the papers was retracted on May 26,...

FILE PHOTO: A woman mourns after her father died due to the coronavirus disease (COVID-19) outside a mortuary of a COVID-19 hospital in New Delhi

No Rest for the Weary: WHO Report Says India Undercounted COVID Deaths by 10x

Banjot Kaur 06/05/2022

Egypt undercounted to a greater extent than India, but...

Spread of the coronavirus disease (COVID-19), in New Delhi

By Lauding Vaccines, What Is India’s COVID Team Sweeping Under the Rug?

Vasudevan Mukunth 20/01/2022

The heads of India's COVID response effort lauded vaccines...

COVID-19 testing in Kolkata

Interview With ICMR Epidemiology Head: What To Make Of the New Testing Strategy?

Banjot Kaur 18/01/2022

A conversation with Samiran Panda on India's testing strategy,...

Screenshot 2020-09-07 at 2.19.04 PM

ICMR Chief Bhargava Takes Strong Stand Against Molnupiravir for COVID

Banjot Kaur 12/01/2022

Balram Bhargava has enumerated six reasons for the ICMR’s...

FILE PHOTO: An experimental COVID-19 treatment pill, called molnupiravir and being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck & Co Inc

Molnupiravir Not Included in India’s COVID-19 Clinical Management Protocol

The experts of the task force cited safety concerns...